References
- Saif MW, Eloubeidi MA, Russo S, et al. A phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of endoscopic genes related to outcome. J Clin Oncol 2005;23:8679–8687
- Saif MW, Katirtzoglou NA, Syrigos KN. Capecitabine: an overview of the side effects and their management. Anticancer Drugs 2008;19:447–464
- Saif MW. Capecitabine versus continuous-infusion 5-Fluorouracil for colorectal cancer: a retrospective efficacy and safety comparison. Clin Colorectal Cancer 2005;5:89–100
- Saif MW. Capecitabine and hand-foot syndrome. Expert Opinionin Drug Safety 2011;10:159–169
- Comandone A, Bretti S, La Grotta G, et al. Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment. Anticancer Res 1993;13:1781–1783
- Gordone KB, Tajuddin A, Guitart J, et al. Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy. Cancer 1995;75:2169–2173
- Saif MW, Diasio R. Is capecitabine safe in patients with gastrointestinal cancer and dihydropyrimidine dehydrogenase deficiency? Clin Colorectal Cancer 2006;5:359–362
- Shahrokni A, Rajebi MR, Saif MW. Toxicity and efficacy of 5-fluorouracil and capecitabine in a patient with TYMS gene polymorphism: a challenge or a dilemma? Clin Colorectal Cancer 2009;8:231–234
- Saif MW, Elfiky A. Identifying and treating fluoropyrimidine-associated cutaneous toxicity in white and non-white patients. J Supp Oncol 2007;5:337–343
- Saif MW, Sandoval A. Atypical hand-and-foot syndrome in an African American patient treated with capecitabine with normal DPD activity: is there an ethnic disparity? Cutan Ocul Toxicol 2007;27:311–315
- Kandil HH, al-Ghanem MM, Sarwat MA, al-Thallab FS. Henna (Lawsonia intermis Linn.) inducing haemolysis among G6PD-deficient newborns. A new clinical observation. Ann Trop Paediatr 1996;16:287–291
- Rahmoun N, Boucherit-Otmani Z, Boucherit K, et al. Antifungal activity of the Algerian Lawsonia inermis (henna). Pharm Biol 2013;51:131–135
- Mikhaeil BR, Badria FA, Maatooq GT, Amer MM. Antioxidant and immunomodulatory constituents of henna leaves. Z Naturforsch 2004;59:468–476
- Uddin N, Siddiqui BS, Begum S, et al. Bioassay-guided isolation of urease and α-chymotrypsin inhibitory constituents from the stems of Lawsonia alba Lam. (Henna). Fitoterapia 2013;84:202–207
- Turan H, Okur M, Kaya E, et al. Allergic contact dermatitis to para-phenylenediamine in a tattoo: a case report. Cutan Ocul Toxicol 2013;32:185–187
- Belhadjali H, Akkari H, Youssef M, et al. Bullous allergic contact dermatitis to pure henna in a 3-year-old girl. Pediatr Dermatol 2011;28:580–581
- Kazandjieva J, Balabanova M, Kircheva K, Tsankov N. Contact dermatitis due to temporary henna tattoos. Skin Med 2010;8:191–192
- Yucel I, Guzin G. Topical henna for capecitabine induced hand-foot syndrome. Invest New Drugs 2008;26:189–192